Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kevinNashon Dec 20, 2018 12:59pm
186 Views
Post# 29141367

RE:doctor lynne gagnon and her team were responsible for

RE:doctor lynne gagnon and her team were responsible forI think this is a reasonable evaluation.  The TD "downgrade" was quite a hit job given PL should have been chopped a long time ago.  The company had to move on to somebody who will be willing to compromise and sign some partnerships.

edrose wrote: our great pipeline not pl
we can't go back but yes pl should have been asked to leave a long time ago but he refused and we have lot of weak board members who are yes people with no back bone

not surprized that thomvest added another voice on board i hope they got rid or planning to get rid of some board members who backed pl poor decisions  so who did they ask to leave

when not if we get deals signed with big pharma they will also want to have a say in how pli is ran
it will take few months to get new experienced people hired so i don't expect lot of changes next few weeks but the unexpected departure of pl is welcomed by most investors and billionaires since it was hard not  to see all the poor business decisions he made and kept making  

2019 will see turn around of our co. and as new ceo starts delivering confidence and sp will increase and as usual analyst will change their targets lot of analysts have no credibility


Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse